Marizyme News and Activities

Marizyme is owned by Qualigen Therapeutics.

Qualigen Therapeutics is a company listed under the stock ticker QLGN (US).

They are in:

• Medical Equipment50%
• Biotechnology50%

View the org chart displaying its 8 main executives

Most searched biographies at Marizyme

• David Barthel, Chief Executive Officer and Director
• Cheryl Rosenberger, Director, Technical Operations
• Marco Barron, Director of Clinical and Global Operations

Create your alert
to follow the executive moves at Marizyme.

Qualigen Therapeutics has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Marizyme

• Press Releases – Marizyme, Inc.

Social media about Marizyme

• Marizyme on Wikipedia, Google News & Yahoo Finance
• Marizyme on LinkedIn, X (Twitter) & YouTube